BIOMAT Database Logo BIOMAT Database Logo

Recent advances in the treatment of human immunodeficiency virus infections with interferons and other biological response modifiers. 1995

O Strannegård
Department of Clinical Virology, Faculty of Medicine, University of Göteborg, Sweden.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

O Strannegård
Interferons and other biological response modifiers in the treatment of Kaposi's sarcoma.
January 1985, Frontiers of radiation therapy and oncology,
O Strannegård
Interferons in malignancy: biological products or biological response modifiers?
May 1988, Journal of the National Cancer Institute,
O Strannegård
Biological response modifiers. Interferons, interleukins, and transfer factor.
March 1989, Annals of allergy,
O Strannegård
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection.
July 1994, Antiviral research,
O Strannegård
Biological response modifiers: interferons, interleukins, recombinant products, liposomal products.
March 1998, The Veterinary clinics of North America. Small animal practice,
O Strannegård
Recent advances in the management of human immunodeficiency virus infection.
September 1997, Mayo Clinic proceedings,
O Strannegård
Condyloma and other infections including human immunodeficiency virus.
February 2010, The Surgical clinics of North America,
O Strannegård
Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer.
December 1984, Cancer,
O Strannegård
Introduction: recent advances in the pathogenesis of human immunodeficiency virus infection.
January 1997, Springer seminars in immunopathology,
O Strannegård
Treatment of human immunodeficiency virus infections.
June 1987, Infectious disease clinics of North America,
Copied contents to your clipboard!